Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04925700 · ClinicalTrials.gov registry record · NA
The Oral Microbiome in OSCC
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04925700 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 20 participants.
The verdict
NCT04925700, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Previous work by a number of scientific teams has revealed that the types of bacteria that colonize the mouth differ between health and pre-cancerous or cancerous oral lesions. The purpose of this study is to investigate the extent of these changes and to correlate the changes with alterations in the activities of the host's own oral tissues. In doing so, we believe we can gain a better understanding of how particular bacterial species, or consortia of species, can result in an individual having an increased risk of the most common type of oral cancer -- oral squamous cell carcinoma. This knowledge may also lead to the identification of salivary biomarkers that can be used for clinical evaluation or screening. In addition, we seek to determine the extent to which a probiotic regimen can help prevent or rectify the disease-related changes in the types of bacterial colonizing the mouth. The microbiome in health, pre-cancerous lesions, and cancerous lesions will be determined from remnant microbial DNA in banked tissue samples. The effects of probiotics on the oral microbiome will be determined from DNA collected from swabs of oral tissue at baseline and then after 3 to 6 months of probiotic usage.
Interventions
- DIETARY_SUPPLEMENT ProDentis Lozenge
- OTHER Placebo Lozenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-04-20 |
| Est. Completion | 2023-10-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04925700
The ClinicalTrials.gov registry entry for NCT04925700 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ProDentis Lozenge is the first listed.
NCT04925700 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04925700 about?
NCT04925700 is a clinical study titled "The Oral Microbiome in OSCC". Previous work by a number of scientific teams has revealed that the types of bacteria that colonize the mouth differ between health and pre-cancerous or cancerous oral lesions. The purpose of this study is to investigate the extent of these changes and to correlate the changes with alterations in th...
What is the current status of trial NCT04925700?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-04-20. Estimated completion is 2023-10-10.
What interventions are being tested in trial NCT04925700?
The interventions under investigation include: ProDentis Lozenge (DIETARY_SUPPLEMENT), Placebo Lozenge (OTHER).
Who is sponsoring clinical trial NCT04925700?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.